Tau Aggregation Assay Service
The in vitro tau aggregation assay can simulate the process of tau protein misfolding and aggregation in vivo, providing an important tool for studying the role of tau protein in disease. For further information regarding the products and services provided, project-specific consultation, and pricing, please submit an inquiry here.
Introduction
Tau protein is a microtubule-associated protein whose primary function is to stabilize microtubule structure in neurons, thereby supporting axonal growth and synaptic plasticity. However, under pathological conditions, tau protein misfolds and aggregates to form neurofibrillary tangles (NFTs), one of the core pathological features of Alzheimer's disease. (AD) Abnormal aggregation of tau protein is not only closely associated with neurodegenerative diseases, but can also induce aggregation of other tau protein molecules through the "seed" effect.
Tau Aggregation Assays at Creative Biolabs
- In Vitro Aggregation Assays
In vitro aggregation experiments are an important method for studying tau protein aggregation, including experiments using recombinant or synthetic tau proteins. These methods typically use fluorescent probes (such as thioflavin T or ThT) to monitor the aggregation process of tau protein in real time. By monitoring changes in ThT fluorescence intensity, the aggregation rate and kinetic properties of tau protein can be evaluated in real time.
Fig.1 A neuronal seed model of tau accumulation.2, 4
- Cell Models
Recent progress in the study of tau protein aggregation, based on cell models, is significant. Our human induced pluripotent stem cell (iPSC) platform can help you use iPSC-derived neuronal models to express fluorescently labeled tau protein through lentiviral transfection, and observe the aggregation process of tau protein in cells.
Fig.2 Modeling tau aggregation using human iPSC-derived neurons.3, 4
- High Throughput Screening
To screen small molecules capable of regulating tau protein aggregation, our researchers have developed a high-throughput screening platform. This platform typically integrates fluorescent probes, automated equipment, and image analysis algorithms to efficiently evaluate the effects of compounds on tau aggregation. Linear regression kinetic analysis is used to monitor the tau aggregation rate in real time and accurately quantify the early aggregation kinetic parameters.
Fig.3 High throughput screening platform.
Applications
- Drug Development: Screening small molecules/antibodies that inhibit abnormal tau aggregation and evaluating dual regulation of compounds on oligomer toxicity and microtubule stability.
- Diagnostic Marker Development: Development of detection kits based on tau oligomers/phosphorylation sites to aid in early screening and efficacy monitoring.
- Disease Mechanism Research: Analyze the transsynaptic transmission mechanism of tau and explore the molecular drivers of neurodegenerative diseases.
To discuss pricing and scheduling for your tau research, please contact us.
References
- Zheng, Huiting, et al. "The Enigma of Tau Protein Aggregation: Mechanistic Insights and Future Challenges." International Journal of Molecular Sciences 25.9 (2024): 4969.
- Amorim, Ines S., et al. "A seeding-based neuronal model of tau aggregation for use in drug discovery." PLoS One 18.4 (2023): e0283941.
- Verheyen, An, et al. "Using human iPSC-derived neurons to model TAU aggregation." PloS one 10.12 (2015): e0146127.
- Distributed under Open Access license CC BY 4.0, without modification.
- iNeuMab™ Anti-Integrin αvβ8 BBB Shuttle Antibody (NRZP-1222-ZP1218) (Cat#: NRZP-1222-ZP1218)
- iNeuMab™ Anti-GARP Antibody (NRP-0422-P1639) (Cat#: NRP-0422-P1639)
- iNeuMab™ Anti-SEZ6 Antibody (NRP-0422-P517) (Cat#: NRP-0422-P517)
- iNeuMab™ Anti-TREM2 Antibody (NRP-0422-P792) (Cat#: NRP-0422-P792)
- iNeuMab™ Anti-Amyloid Beta 1-15 Antibody (NRP-0422-P867) (Cat#: NRP-0422-P867)
- iNeuMab™ Anti-pTau Antibody (NRP-0422-P1719) (Cat#: NRP-0422-P1719)
- iNeuMab™ Anti-ApoC3 BBB Shuttle Antibody (NRZP-1022-ZP3503) (Cat#: NRZP-1022-ZP3503)
- iNeuMab™ Anti-CD20 Antibody (NRP-0422-P1230) (Cat#: NRP-0422-P1230)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P2293) (Cat#: NRP-0422-P2293)
- iNeuMab™ Anti-TREM2 BBB Shuttle Antibody (NRZP-1022-ZP4114) (Cat#: NRZP-1022-ZP4114)
- Human Brain Astroblastoma U-87 MG (Cat#: NCL2110P117)
- Mouse Retinal Ganglion Cells (Cat#: NCL2110P145)
- Mouse Glioma Cell Line GL-261-Luc (Cat#: NCL-2108P06)
- Human Brain Microvascular Endothelial Cells (Cat#: NCL-2103-P133)
- Rat Retinal Muller Cell Line, Immortalized (Cat#: NCL-21P6-192)
- Green Fluorescent Tau cell Line (Cat#: NCL2110P219)
- Rat Glioma Cell Line C6 (Cat#: NCL2110P346)
- Mouse Glioma Cell Line GL261 (Cat#: NCL-2108P28)
- Human Neurons Isolated from Cortex (Cat#: NCL-21P6-023)
- Human Astrocytes, Immortalized (Cat#: NCL-2105-P182-AM)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- AAV2/9-hEF1a-fDIO-eNpHR 3.0-mCherry-WPRE-pA (Cat#: NTA-2012-ZP78)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)